RAB22A and osteosarcoma: This process is promoted by PINK1 kinase via phosphorylating Rab22a‐NeoF1 at serine120, and Sorafenib and Regorafenib can diminish osteosarcoma lung metastasis induced by Rab22a‐NeoF1 through upregulating PINK1.